Minerva Neurosciences (NERV) Share-based Compensation (IS) (2017 - 2026)
Minerva Neurosciences (NERV) reported Share-based Compensation (IS) of $2.27 million for Q2 2026, up 662.1% from $298,218 a year earlier but down 73.9% from the prior quarter.
Powered by 
Analysis
Minerva Neurosciences (NERV) Share-based Compensation (IS) (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Minerva Neurosciences' Share-based Compensation (IS) came in at $11.72 million, up 916.2% year-over-year; for FY2025, it was $1.33 million, up 0.1% from FY2024.
- Share-based Compensation (IS) has a three-year compound annual growth rate of -31.4% (FY2022 to FY2025).
- By year, Share-based Compensation (IS) came in at $1.33 million in FY2024 (-32.7%), $1.97 million in FY2023 (-52.1%) and $4.11 million in FY2022.
- Five-year quarterly Share-based Compensation (IS) spans a low of $249,650 in Q4 2024 and a high of $8.71 million in Q1 2026.
- Year over year, Share-based Compensation (IS) gained in two of the last seven quarters, with growth averaging 88.1%.
- The high point for year-over-year Share-based Compensation (IS) in five years was Q2 2026 (growth of 662.1%); the low point was Q1 2023 (a decline of 64.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $8.71 million (Q1 2026), $459,028 (Q4 2025) and $272,897 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | - |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Minerva Neurosciences | 160.57 Mn | 160.57 Mn | - | 2.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 8.71 Mn |
| Dec 31, 2025 | 459,028.00 |
| Sep 30, 2025 | 272,897.00 |
| Jun 30, 2025 | 298,218.00 |
| Mar 31, 2025 | 297,229.00 |
| Dec 31, 2024 | 249,650.00 |
| Sep 30, 2024 | 307,708.00 |
| Jun 30, 2024 | 329,318.00 |
| Mar 31, 2024 | 438,849.00 |
| Dec 31, 2023 | 611,064.00 |
| Sep 30, 2023 | 371,943.00 |
| Jun 30, 2023 | 608,915.00 |
| Mar 31, 2023 | 376,459.00 |
| Dec 31, 2022 | 947,684.00 |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 1.05 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.38 Mn |
API Access
Minerva Neurosciences Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=NERV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "NERV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=NERV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();